Request Demo
Last update 10 Oct 2025
Autologous dendritic cell-tumor fusion vaccine(Mayo Clinic)
Last update 10 Oct 2025
Overview
Basic Info
Drug Type Therapeutic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Related
1
Clinical Trials associated with Autologous dendritic cell-tumor fusion vaccine(Mayo Clinic)NCT01239875
LS1081, "A Pilot Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation or Intradermally for Patients With B-Cell Non-Hodgkin's Lymphoma"
100 Clinical Results associated with Autologous dendritic cell-tumor fusion vaccine(Mayo Clinic)
Login to view more data
100 Translational Medicine associated with Autologous dendritic cell-tumor fusion vaccine(Mayo Clinic)
Login to view more data
100 Patents (Medical) associated with Autologous dendritic cell-tumor fusion vaccine(Mayo Clinic)
Login to view more data
100 Deals associated with Autologous dendritic cell-tumor fusion vaccine(Mayo Clinic)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Adult Lymphoblastic Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| B-cell lymphoma refractory | Phase 1 | United States | 01 Nov 2010 | |
| Follicular Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| Immunoblastic Large-Cell Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| Lymphomatoid Granulomatosis | Phase 1 | United States | 01 Nov 2010 | |
| Mantle-Cell Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| Marginal Zone B-Cell Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| Small Lymphocytic Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma | Phase 1 | United States | 01 Nov 2010 | |
| Waldenstrom Macroglobulinemia | Phase 1 | United States | 01 Nov 2010 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free